The Research & Creation Chair: Cancerology and Immunology aims to foster innovative and interdisciplinary artistic and scientific research on the issues of the call, highlighting the synergies between scientific research in the field of cancer and immunology and research-creation. This initiative seeks to provide significant national and international visibility to this research at the crossroads of disciplines and knowledge systems, thus contributing to the outreach of cancer and immunology research through art-science collaborations and research-creation in this domain.
The residency period is for 10 months between from 1 September 2025 and 3 July 2026.
Focusing on creation, transmission, and impact, the chair’s residents are expected to develop their research around 1 or more of these 3 fundamental axes:
- Reflection on the therapeutic use of artistic practices by clinicians in managing cancer and its therapies (primarily immunotherapy). Since patient access is not guaranteed, this chair cannot host art therapy projects as such.
- Reflection on social representations of cancer and its therapy for producing illustrated books, films, etc.
- Reflection on the relationships between artistic practices and clinical and/or scientific practices from a more epistemological perspective.
Regarding artists, the chair can accommodate multiple phases of their project, provided these phases require sustained dialogue with researchers from academic disciplines during the conception of a work, thought, or writing (whether theoretical, poetic, or otherwise), early in the process or later in the development phase but before production.
Iméra does not offer production facilities but provides a shared, unequipped studio, possibly shared with other artists (on average, two artists share this space), allowing for a variety of knowledge configurations that can also be spatialised and materialised in different formats. This can include semi-public or private exhibitions to share research moments and preliminary outcomes.
Artists receive a salary or allowance, depending on their status, of 2,000 EUR per month. Residents also benefit from travel expense coverage and free accommodation at the Iméra site.
